157 related articles for article (PubMed ID: 38343764)
1. Intraductal papillary mucinous neoplasms of the pancreas: Cytologic-histologic correlation study and evaluation of the cytologic accuracy in identifying high-grade dysplasia/invasive adenocarcinoma.
Serinelli S; Khurana KK
Cytojournal; 2024; 21():6. PubMed ID: 38343764
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytologic Evaluation of Intraductal Papillary Mucinous Neoplasm and Mucinous Cystic Neoplasms of Pancreas.
Gilani SM; Adeniran AJ; Cai G
Am J Clin Pathol; 2020 Sep; 154(4):559-570. PubMed ID: 32589187
[TBL] [Abstract][Full Text] [Related]
3. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.
Salla C; Chatzipantelis P; Konstantinou P; Karoumpalis I; Sakellariou S; Pantazopoulou A; Manika Z
JOP; 2007 Nov; 8(6):715-24. PubMed ID: 17993724
[TBL] [Abstract][Full Text] [Related]
5. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
6. Plectin-1 as a Biomarker of Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Multicenter Study.
Moris M; Dawson DW; Jiang J; Lewis J; Nassar A; Takeuchi KK; Lay AR; Zhai Q; Donahue TR; Kelly KA; Crawford HC; Wallace M
Pancreas; 2016 Oct; 45(9):1353-8. PubMed ID: 27101571
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of intraductal papillary mucinous neoplasm of the pancreas is highly predictive of pancreatic neoplasia.
Emerson RE; Randolph ML; Cramer HM
Diagn Cytopathol; 2006 Jul; 34(7):457-62. PubMed ID: 16783773
[TBL] [Abstract][Full Text] [Related]
8. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic yield of EUS-FNA-based cytology distinguishing malignant and benign IPMNs: a systematic review and meta-analysis.
Suzuki R; Thosani N; Annangi S; Guha S; Bhutani MS
Pancreatology; 2014; 14(5):380-4. PubMed ID: 25278308
[TBL] [Abstract][Full Text] [Related]
10. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
Smith AL; Abdul-Karim FW; Goyal A
Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic juice cytology as sensitive test for detecting pancreatic malignancy in intraductal papillary mucinous neoplasm of the pancreas without mural nodule.
Kawada N; Uehara H; Nagata S; Tomita Y; Nakamura H
Pancreatology; 2016; 16(5):853-8. PubMed ID: 27459913
[TBL] [Abstract][Full Text] [Related]
12. EUS-guided confocal laser endomicroscopy: prediction of dysplasia in intraductal papillary mucinous neoplasms (with video).
Krishna SG; Hart PA; DeWitt JM; DiMaio CJ; Kongkam P; Napoleon B; Othman MO; Yew Tan DM; Strobel SG; Stanich PP; Patel A; Luthra AK; Chan MQ; Blaszczak AM; Lee D; El-Dika S; McCarthy ST; Walker JP; Arnold CA; Porter K; Conwell DL
Gastrointest Endosc; 2020 Mar; 91(3):551-563.e5. PubMed ID: 31542380
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
14. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.
Walter TC; Steffen IG; Stelter LH; Maurer MH; Bahra M; Faber W; Klein F; Bläker H; Hamm B; Denecke T; Grieser C
Eur Radiol; 2015 May; 25(5):1329-38. PubMed ID: 25433414
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary mucinous neoplasm of the pancreas: Cytomorphology, imaging, molecular profile, and prognosis.
Geramizadeh B; Marzban M; Shojazadeh A; Kadivar A; Maleki Z
Cytopathology; 2021 Jul; 32(4):397-406. PubMed ID: 33792980
[TBL] [Abstract][Full Text] [Related]
16. Imaging and Cytopathological Criteria Indicating Malignancy in Mucin-Producing Pancreatic Neoplasms: A Series of 68 Histopathologically Confirmed Cases.
Salla C; Karvouni E; Nikas I; Ikonomakis A; Konstantinou P; Karoumpalis I; Sepsa A; Papaparaskeva K; Tsopanomichalou M; Georgiadou D; Kostopoulou A; Tsiotos G; Theocharis S; Sergentanis TN; Politi E
Pancreas; 2018; 47(10):1283-1289. PubMed ID: 30308535
[TBL] [Abstract][Full Text] [Related]
17. Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain.
Hara T; Ikebe D; Odaka A; Sudo K; Nakamura K; Yamamoto H; Itami M; Hirata T; Kashimura J; Yamaguchi T
Ann Surg; 2013 Jun; 257(6):1103-11. PubMed ID: 23364699
[TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
19. Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms.
Penheiter AR; Deelchand DK; Kittelson E; Damgard SE; Murphy SJ; O'Brien DR; Bamlet WR; Passow MR; Smyrk TC; Couch FJ; Vasmatzis G; Port JD; Marjańska M; Carlson SK
Pancreatology; 2018 Jan; 18(1):46-53. PubMed ID: 29170050
[TBL] [Abstract][Full Text] [Related]
20. Mural nodule of 10 mm or larger as predictor of malignancy for intraductal papillary mucinous neoplasm of the pancreas: Pathological and radiological evaluations.
Kawada N; Uehara H; Nagata S; Tsuchishima M; Tsutsumi M; Tomita Y
Pancreatology; 2016; 16(3):441-8. PubMed ID: 26804002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
